Hoth Therapeutics Inc (HOTH) — Strategic Asset Allocation Index

Latest as of September 2025: 3.8%

Hoth Therapeutics Inc (HOTH) has a Strategic Asset Allocation Index of 3.8% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $311.51K) total $311.51K, measured against net assets of $8.23 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

3.8%
Strategic Assets / Net Assets

Strategic Assets

$311.51K
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$8.23 Million
USD

Hoth Therapeutics Inc Strategic Asset Allocation Index (2017–2024)

This chart shows how Hoth Therapeutics Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 3.8%, representing strategic assets of $311.51K against net assets of $8.23 Million USD. Explore Hoth Therapeutics Inc (HOTH) cash flow conversion to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Hoth Therapeutics Inc (2017–2024)

The table below presents the year-by-year Strategic Asset Allocation Index for Hoth Therapeutics Inc from 2017 to 2024, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Hoth Therapeutics Inc.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2024 0.5% $36.82K $- $36.82K $6.88 Million ▲ +0.1 pp
2023 0.4% $37.40K $- $37.40K $9.54 Million ▼ -0.3 pp
2022 0.6% $33.00K $- $33.00K $5.12 Million ▼ -3.5 pp
2021 4.1% $410.00K $- $410.00K $9.88 Million ▼ -4.7 pp
2020 8.8% $410.00K $- $410.00K $4.65 Million ▲ +8.8 pp
2019 0.0% $1.04K $1.04K $- $2.40 Million ▼ -1.4 pp
2018 1.5% $2.27K $2.27K $- $154.97K ▲ +1.2 pp
2017 0.3% $3.49K $3.49K $- $1.18 Million —
pp = percentage points